Thymalfasin Combined With Chemotherapy and Immunotherapy for Neoadjuvant Treatment of Triple-Negative Breast Cancer：A Prospective, Open-Label, Single-Center, Phase II, Randomized Controlled Clinical Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07884201

Title field or adapter rule

{'original_value': 'Thymalfasin Combined With Chemotherapy and Immunotherapy for Neoadjuvant Treatment of Triple-Negative Breast Cancer：A Prospective, Open-Label, Single-Center, Phase II, Randomized Controlled Clinical Study', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:30.579949+00:00

Published At

2026-10-20T00:00:00+00:00

Record Updated At

2026-10-20

Source Retrieved At

2026-10-31T22:18:22.973355+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Breast Cancer", "TNBC - Triple-Negative Breast Cancer", "Immunotherapy"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-20", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07884201"

protocolSection.identificationModule.officialTitle

"Thymalfasin Combined With Chemotherapy and Immunotherapy for Neoadjuvant Treatment of Triple-Negative Breast Cancer\uff1aA Prospective, Open-Label, Single-Center, Phase II, Randomized Controlled Clinical Study"

protocolSection.statusModule.overallStatus

"NOT_YET_RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Breast Cancer (protocolSection.conditionsModule.conditions)
• TNBC - Triple-Negative Breast Cancer (protocolSection.conditionsModule.conditions)
• Immunotherapy (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Thymalfasin Arm'], 'description': 'Thymalfasin 1.6 mg subcutaneous injection', 'name': 'Thymalfasin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Thymalfasin (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.